Bright Minds Biosciences Inc. (DRUG)

NASDAQ: DRUG · Real-Time Price · USD

89.14

+3.96 (4.65%)

Apr 14, 2026, 4:00 PM EDT - Market closed

Bright Minds Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 14, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Market Capitalization	875	429	5	6	20	85
Market Cap Growth	234.61%	8742.00%	-18.98%	-70.74%	-75.79%	-
Enterprise Value	810	393	0	0	14	67
Last Close Price	89.14	60.66	1.17	1.60	6.15	35.71
PB Ratio	13.44	7.29	1.19	1.23	2.67	5.51
P/TBV Ratio	13.44	7.29	1.19	1.23	2.67	5.52
Debt / Equity Ratio	0.00	0.00	0.02	0.01	0.01	-
Net Debt / Equity Ratio	-1.00	-1.01	-1.01	-1.01	-1.09	-1.02
Quick Ratio	56.59	35.68	10.92	24.16	8.00	31.12
Current Ratio	57.37	36.10	11.32	24.26	8.11	31.38
Return on Equity (ROE)	-26.98%	-27.93%	-46.18%	-86.02%	-99.95%	-85.94%
Return on Assets (ROA)	-15.72%	-18.80%	-25.28%	-47.45%	-57.32%	-51.52%
Return on Capital Employed (ROCE)	-21.00%	-16.60%	-47.10%	-109.10%	-138.80%	-44.40%
Earnings Yield	-1.65%	-2.04%	-42.70%	-90.90%	-53.20%	-8.09%
Buyback Yield / Dilution	-48.78%	-59.58%	-15.87%	-50.58%	-37.64%	-148.42%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q